Cargando…
Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study
Dexamethasone provides benefits in patients with coronavirus disease 2019 (COVID-19), although data regarding immunological profiles and viral clearance are limited. This study aimed to evaluate for differences in biomarkers among patients with severe COVID-19 who did and did not receive dexamethaso...
Autores principales: | Kim, Won-Young, Kweon, Oh Joo, Cha, Min Jae, Baek, Moon Seong, Choi, Seong-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253399/ https://www.ncbi.nlm.nih.gov/pubmed/34214123 http://dx.doi.org/10.1371/journal.pone.0254167 |
Ejemplares similares
-
Biomarkers Associated with Failure of Liberation from Oxygen Therapy in Severe COVID-19: A Pilot Study
por: Kweon, Oh Joo, et al.
Publicado: (2021) -
Patterns of inflammatory immune responses in patients with septic shock receiving vitamin C, hydrocortisone, and thiamine: clustering analysis in Korea
por: You, Seung-Hun, et al.
Publicado: (2023) -
Clinical and radiological findings of adult hospitalized patients with community-acquired pneumonia from SARS-CoV-2 and endemic human coronaviruses
por: Baek, Moon Seong, et al.
Publicado: (2021) -
Formyl Peptide Receptor 2 Activation Ameliorates Dermal Fibrosis and Inflammation in Bleomycin-Induced Scleroderma
por: Park, Gyu Tae, et al.
Publicado: (2019) -
Preliminary Study on Quantitative Sleep EEG Characteristics in Patients with Schizophrenia
por: Oh, Seong Min, et al.
Publicado: (2017)